CO227 Systematic Literature Review and Bayesian Network Meta-Analysis of Sugemalimab Plus Chemotherapy vs. Other First-Line Treatments for Metastatic Non-Small Cell Lung Cancer Without Sensitizing eGFR, ALK, ROS1, or RET Alterations
Abstract
Authors
Aneta Gomulka-Pilat Magdalena Kaczanowska Agnieszka Kopiec Izabela Pieniazek